The roughly 600,000-square-foot campus at Generation Park will be designed to grow and adapt for decades...
SpecificiT Pharma Competitors or Alternatives
SpecificiT Pharma's top competitors include Surface Oncology, NexImmune and Bristol-Myers Squibb.
SpecificiT Pharma VS Surface Oncology
Surface Oncology is one of SpecificiT Pharma's top competitors. Surface Oncology was founded in 2014 in Cambridge, Massachusetts. Like SpecificiT Pharma, Surface Oncology also operates in the Biotechnology industry. Surface Oncology generates $49.3M more revenue than SpecificiT Pharma.
SpecificiT Pharma VS NexImmune
NexImmune is a top competitor of SpecificiT Pharma. NexImmune was founded in 2011, and is headquartered in Gaithersburg, Maryland. Like SpecificiT Pharma, NexImmune also competes in the Biotechnology field. NexImmune generates $ less revenue vs. SpecificiT Pharma.
SpecificiT Pharma VS Bristol-Myers Squibb
Bristol-Myers Squibb is seen as one of SpecificiT Pharma's top competitors. Bristol-Myers Squibb is headquartered in Princeton, New Jersey, and was founded in 1858. Like SpecificiT Pharma, Bristol-Myers Squibb also operates in the Pharmaceuticals & Biotechnology field. Bristol-Myers Squibb generates 4,918,600% the revenue of SpecificiT Pharma.
Looking for similar companies to SpecificiT Pharma?
Similar Companies
Biotechnology companies in Montreal
See 80 companies
Biotechnology companies in QuebecSee 214 companies
Pharmaceuticals & Biotechnology companies in MontrealSee 157 companies
Pharmaceuticals & Biotechnology companies in QuebecSee 411 companies
Biotechnology companies in CanadaSee 1,205 companies
Companies in Montreal with employees in 1-25 rangeSee 1,223 companies
Pharmaceuticals & Biotechnology companies in CanadaSee 2,099 companies
Companies in Quebec with employees in 1-25 rangeSee 2,618 companies
Companies in Montreal with revenue in $100K-5.0M rangeSee 2,849 companies
Trending News for SpecificiT Pharma and SpecificiT Pharma's Competitors
Innate Pharma SA, a global, clinical─stage biotechnology company developing immunotherapies for cancer patients, announced that, subject to the closing...
Sales rise 29.73% to Rs 682.79 crore...
TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, a leader in AI-powered Tissue Intelligence, which integrates multimodal tissue image analysis with clinical...
Arcus Biosciences, Inc. ( NYSE:RCUS - Free Report ) - HC Wainwright boosted their Q3 2026 earnings per share (EPS) estimates for Arcus Biosciences in a...
The authorisation is supported by the Phase III REMIX-1 and REMIX-2 trials,...
Handelsbanken Fonder AB lowered its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.4% during the 2nd quarter, according to its most r...
NEW YORK CITY (dpa-AFX) - Bristol Myers Squibb (BMY) announced Monday an investment of approximately $2.3 billion in the U.S., while selecting Houston,...
News of the joint venture comes months after AstraZeneca vowed to spend $15 billion in China by the end of the decade....
Novartis India will re-acquire exclusivity and secure market access for the products for which Dr. Reddy's was granted exclusive and non-transferable r...
Frequently Asked Questions about SpecificiT Pharma
Who are SpecificiT Pharma's top competitors?
SpecificiT Pharma's top 3 competitors are Surface Oncology, NexImmune, Bristol-Myers Squibb.Who is similar to SpecificiT Pharma?
Surface Oncology is the most similar to SpecificiT Pharma. NexImmune and Bristol-Myers Squibb are also similar to SpecificiT Pharma.
Are SpecificiT Pharma and Surface Oncology competitors?
Yes, Surface Oncology is one of SpecificiT Pharma’s top competitors.